Catalog No.
RXX54701
Species reactivity
Entacmaea quadricolor
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
IF: 1:100-1:500, WB: 1:1000-1:10000
Target
GFP like chromoprotein, red fluorescent protein, Red fluorescent protein eqFP611, RFP, RFP tag
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q8ISF8
Applications
IF, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4 ℃ short term (1-2 weeks).
Store at -20 ℃ 12 months.
Store at -80 ℃ long term.
Clone ID
R1A04
Pathophysiological mechanisms of hair follicle regeneration and potential therapeutic strategies., PMID:40518544
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors., PMID:40518465
Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma., PMID:40518441
Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits., PMID:40518438
[Analysis of inhalant and food allergen-specific IgE in a children's hosipital in Suzhou City from 2017 to 2024]., PMID:40518417
[Analysis of sensitization characteristics and changing trends of common allergens in a children's hospital in Shanghai City from 2020 to 2024]., PMID:40518416
[Analysis of the clinical efficacy and safety of dupilumab in the treatment of patients with moderate to severe atopic dermatitis complicated with asthma]., PMID:40518414
[Advances in the evaluation and prediction of the efficacy of allergen-specific immunotherapy]., PMID:40518411
Highly sensitive nanobody-immunosensor for macrophage-capping protein., PMID:40518371
Development of Thyrotoxicosis With Positive TSH Receptor Antibody and Transition to Hypothyroidism in a Patient With Unresectable Hepatocellular Carcinoma During Combined Atezolizumab and Bevacizumab Therapy: A Case Report and Review of the Literature., PMID:40518311
Purification of Recombinant Monoclonal Antibodies from Transgenic Chicken Eggs and Removal of Egg-White Proteins., PMID:40518304
Seroprevalence of Neospora caninum infection in cattle and yaks in the northern mountainous regions of Kyrgyzstan., PMID:40518251
Investigation of Schmallenberg virus and update on the serological status of Toxoplasma gondii in goat herds in the semiarid region of Pernambuco state, Brazil., PMID:40518245
Molecular chaperones: A revolutionary approach for increased solubility of recombinant mAbs from bacterial and yeast systems., PMID:40518128
Characteristics of Kawasaki disease in children with a history of COVID-19., PMID:40517900
Journal of Oral Biosciences Proteolytic N-terminal processing of Mfa proteins in the periodontal pathogen Porphyromonas gingivalis., PMID:40517809
Engineered MAP30ER: A plant toxin-derived platform for EGFR-Targeted delivery of protein and chemotherapeutic payloads., PMID:40517671
Interlaboratory study to assess precision and reproducibility of the meningococcal antigen surface expression (MEASURE) assay to quantify factor H binding protein expression at the surface of meningococcal serogroup B strains., PMID:40517645
Advances in the Management of Relapsed/Refractory CLL and Richter Transformation., PMID:40517442
T-Cell Redirecting Strategies in Large B-Cell Lymphoma and Follicular Lymphoma., PMID:40517438
Positive coactivator PC4 shows dynamic nucleolar distribution required for rDNA transcription and protein synthesis., PMID:40517275
Doubling multiplexed imaging capability via spatial expression pattern-guided protein pairing and computational unmixing., PMID:40517167
Potential blocker of SARS-CoV entry and a narrow functionality of its spike protein motifs on Qubevirus platform., PMID:40516871
Nanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations., PMID:40516870
Current and emerging strategies for subcutaneous delivery of high-concentration and high-dose antibody therapeutics., PMID:40516697
WAYPOINT: Are we there yet for patients with nasal polyposis?, PMID:40516522
Modular high-throughput platform for the purification of scFvs and multispecific antibody-based therapeutics., PMID:40516489
Identification of candidate vaccine antigens using 2-D gel electrophoresis and immunoproteomics for cross protection against Glaesserella parasuis., PMID:40516376
m6A-REFII: an antibody-independent tool for in situ visualizing cellular specific RNA m6A compatible with protein immunofluorescence staining., PMID:40516020
The immune response of Boschveld chickens to a Newcastle disease vaccination program designed for commercial layers., PMID:40515962
Prevalence and clinical significance of autoantibodies to sulphite oxidase and glycogen phosphorylase in Chinese primary biliary cholangitis patients., PMID:40515960
RNA-Binding Protein Immunoprecipitation 1 (RIP) Assay to Investigate the Interactions Between Viral RNA and Host Proteins., PMID:40515923
Determination of Protein Ubiquitination After Protein Denaturation in Virus-Host Interactions., PMID:40515897
Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia., PMID:40515863
Response to telitacicept in optic neuritis associated with Sjogren's syndrome: a case report and literature review., PMID:40515854
Basal cell adenoma with S100 protein-positive "stroma": a distinct triphasic salivary gland neoplasm characterized by CTNNB1 mutation., PMID:40515848
The Immunology of Alpha-Gal Syndrome: History, Tick Bites, IgE, and Delayed Anaphylaxis to Mammalian Meat., PMID:40515672
A comparison of JC virus assay performance provided with originator and biosimilar natalizumab., PMID:40515643
Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?, PMID:40515642
Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances., PMID:40515614
First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer., PMID:40515479
Pooled biomarker analysis of the association of baseline T regulatory cells with response and T-cell recovery profiles with blinatumomab treatment., PMID:40515477
Systemic and Phloem-Specific Protein Targeting by High Affinity Nanobodies Expressed From a Plant RNA Virus Vector., PMID:40515423
Anti-melanoma differentiation-associated gene 5 antibody associated rapidly progressive interstitial lung disease in a pediatric patient: a case report., PMID:40514742
Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study., PMID:40514717
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study., PMID:40514709
Myomedin variants developed for in vitro PD-L1 diagnostics in tissue samples of non-small cell lung carcinoma patients., PMID:40514707
Pharmacokinetic bioequivalence of the fixed-dose combination of pertuzumab and trastuzumab administered subcutaneously using a handheld syringe or an on-body delivery system., PMID:40514611
A New Vaccine Candidate Expressing JUNV GP1-GP2 Against Argentine Hemorrhagic Fever Based on Baculovirus Surface Display., PMID:40514553
Multiplex and multimodal mapping of variant effects in secreted proteins via MultiSTEP., PMID:40514537
For research use only. Not for human or drug use.
